Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice

International Journal of Neuropsychopharmacology

Volumn 16, Issue 10, 2013, Pages 2245-2257

  Dobarro, Marta ^a   Gerenu, Gorka ^a   Ramírez, María J ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Antihypertensive; BACE; BDNF; insulin degrading enzyme; JNK1

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; PROPRANOLOL; PROTEIN KINASE B; SYNAPTOPHYSIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL SURVIVAL; CELL VIABILITY; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; FEMALE; GENOTYPE; HIPPOCAMPUS; LOCOMOTION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; WORKING MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEAR; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 8; MOTOR ACTIVITY; MUTATION; NEURONAL PLASTICITY; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROPRANOLOL; PROTO-ONCOGENE PROTEINS C-AKT; RECOGNITION (PSYCHOLOGY); SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84885649255     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145713000631     Document Type: Conference Paper

References (59)

1. Aisa B, Tordera R, Lasheras B, Del Río J, Ramírez MJ (2007) Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 32:256-266
2. Ashe KH, Zahs KR (2010) Probing the biology of Alzheimer's disease in mice. Neuron 66:631-645
3. Aston-Jones G, Rajkowski J, Cohen J (2000) Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res 126:165-182
4. Barde YA (1994) Neurotrophins: A family of proteins supporting the survival of neurons. Prog Clin Biol Res 390:45-56
5. Bellew KM, Pigeon JG, Stang PE, Fleischman W, Gardner RM, Baker WW (2004) Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 18:208-213
6. Bellucci A, Rosi MC, Grossi C, Fiorentini A, Luccarini I, Casamenti F (2007) Abnormal processing of tau in the brain of aged TgCRND8 mice. Neurobiol Dis 27:328-338
7. Cahill L, McGaugh JL (1996) Modulation of memory storage. Curr Opin Neurobiol 6:237-242
8. Campbell HL, Tivarus ME, Hillier A, Beversdorf DQ (2008) Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility. Pharmacol Biochem Behav 88:222-229
9. Cuadrado-Tejedor M, Hervias I, Ricobaraza A, Puerta E, Pérez-Roldán JM, García-Barroso C, Franco R, Aguirre N, García-Osta A (2011) Sildenafil restores cognitive function without affecting Aβburden in an Alzheimer's disease mouse model. Neurobiol Aging 164:2029-2041
10. Cummings JL, Cole G (2002) Alzheimer disease. J Am Med Assoc 287:2335-2338
11. Dang M, Dubbin K, D'Aiello A, Hartmann M, Lodish H, Herrlich A (2011) Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulus. J Biol Chem 286:17704-17713
12. Ennaceur A, Delacour J (1988) A new one trial-test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31:47-59
13. Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J (2005) Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr Alzheimer Res 2:3-18
14. Flores O, Núñez H, Pérez H, Morgan C, Soto-Moyano R, Valladares L, Burgos H, Olivares R, Hernández A (2010) beta-Adrenoceptor blockade depresses molecular andfunctional plasticities in the rat neocortex. Brain Res Bull 82:284-288
15. Gil-Bea FJ, Gerenu G, Aisa B, Kirazov LP, Schliebs R, Ramírez MJ (2012) Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice. Neurobiol Dis 48:439-346
16. Guillozet AL, Weintraub S, Mash DC, Mesulam MM (2003) Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 60:729-736
17. Guo Z, Viitanen M, Winblad B, Fratiglioni L (1999) Low blood pressure and incidence of dementia in a very old sample: Dependent on initial cognition. J Am Geriatr Soc 47:723-726
18. Hajjar I, Keown M, Frost B (2005) Antihypertensive agents for aging patients who are at risk for cognitive dysfunction. Curr Hypertens Rep 7:466-473
19. Hanger DP, Seereeram A, Noble W (2009) Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev Neurother 9:1647-1666
20. Hardy J (2006) Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr Alzheimer Res 3:71-73
21. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356
22. Hoffman LB, Schmeidler J, Lesser GT, Beeri MS, Purohit DP, Grossman HT, Haroutunian V (2009) Less Alzheimer disease neuropathology in medicated hypertensive than non hypertensive persons. Neurology 72:1720-1726
23. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102
24. In't Veld B.A. Ruitenberg A, Hofman A, Stricker BH, Breteler MM (2001) Antihypertensive drugs and incidence of dementia: The Rotterdam study. Neurobiol Aging 22:407-412
25. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat Med 6:143-150
26. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC (2006) Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Arch Neurol 63:686-692
27. Kögel D, Schomburg R, Copanaki E, Prehn JH (2005) Regulation of gene expression by the amyloid precursor protein: Inhibition of the JNK/cJun pathway. Cell Death Differ 12:1-9
28. Kurochkin IV, Goto S (1994) Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 345:33-37
29. Leach PT, Poplawski SG, Kenney JW, Hoffman B, Liebermann DA, Abel T, Gould TJ (2012) Gadd45b knockout mice exhibit selective deficits in hippocampus-dependent long-term memory. Learn Mem 19:319-324
30. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group (2004) The study on COgnition and prognosis in the elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertens 22:1605-1612
31. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65:545-551
32. Maruyama J, Naguro I, Takeda K, Ichijo H (2009) Stressactivated MAP kinase cascades in cellular senescence. Curr Med Chem 16:1229-1235
33. Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce-Levie K, Cheng IH, Yu GQ, Mucke L (2009) Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Aβoligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci 29:1977-1986
34. Mouri A, Noda Y, Hara H, Mizoguchi H, Tabira T, Nabeshima T (2007) Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J 163:2135-2148
35. Murchison CF, Zhang XY, Zhang WP, Ouyang M, Lee A, Thomas SA (2004) A distinct role for norepinephrine in memory retrieval. Cell 117:131-143
36. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15:331-337
37. Otth C, Concha II, Arendt T, Stieler J, Schliebs R, González- Billault C, Maccioni RB (2002) AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis 4:417-430
38. Peskind ER, Tsuang DW, Bonner LT, Pascualy M, Riekse RG, Snowden MB, Thomas R, Raskind MA (2005) Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: A placebo-controlled study. Alzheimer Dis Assoc Disord 19:23-28
39. Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W (2000) Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: The HAAS. Honolulu-Asia aging study. Neurobiol Aging 21:57-62
40. Prince M, Rabe-Hesketh S, Brennan P (1998) Do antiarthritic drugs decrease the risk for cognitive decline? An analysis based on data from the MRC treatment trial of hypertension in older adults. Neurology 50:374-379
41. Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisited. FASEB J 22:659-661
42. Reed MN, Liu P, Kotilinek LA, Ashe KH (2010) Effect size of reference memory deficits in the Morris water maze in Tg2576 mice. Behav Brain Res 212:115-120
43. Ricobaraza A, Cuadrado-Tejedor M, Marco S, Pérez-Otaño I, García-Osta A (2012) Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 22:1040-1050
44. Roozendaal B, Hahn EL, Nathan SV, de Quervain DJ, McGaugh JL (2004) Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. J Neurosci 24:8161-8169
45. Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, Barrett T, Kim JK, Davis RJ (2008) A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322:1539-1543
46. Sasaki A, Shoji M, Harigaya Y, Kawarabayashi T, Ikeda M, Naito M, Matsubara E, Abe K, Nakazato Y (2002) Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Virchows Arch 441:358-367
47. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791
48. Shankle WR, Nielson KA, Cotman CW (1995) Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients. Alzheimer Dis Assoc Disord 9:233-237
49. Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res Rev 33:199-227
50. Skoog I, Gustafson D (2006) Update on hypertension and Alzheimer's disease. Neurol Res 28:605-611
51. Sparks DL, Scheff SW, Liu H, Landers T, Danner F, Coyne CN, Hunsaker JC III (1996) Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: Comparison to confirmed Alzheimer's disease patients. J Neurol Sci 138:97-104
52. Taglialatela G, Hogan D, Zhang WR, Dineley KT (2009) Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200:95-99
53. Tanzi RE, Moir RD, Wagner SL (2004) Clearance of Alzheimer's Abeta peptide: The many roads to perdition. Neuron 43:605-608
54. Tartaglia N, Du J, Tyler WJ, Neale E, Pozzo-Miller L, Lu B (2001) Protein synthesis-dependent and -independent regulation of hippocampal synapses by brain-derived neurotrophic factor. J Biol Chem 276:37585-37593
55. Tomidokoro Y, Ishiguro K, Harigaya Y, Matsubara E, Ikeda M, Park JM, Yasutake K, Kawarabayashi T, Okamoto K, Shoji M (2001) Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci Lett 299:169-172
56. Valtorta F, Pennuto M, Bonanomi D, Benfenati F (2004) Synaptophysin: Leading actor or walk-on role in synaptic vesicle exocytosis? Bioessays 26:445-453
57. van der Heide LP, Ramakers GM, Smidt MP (2006) Insulin signaling in the central nervous system: Learning to survive. Prog Neurobiol 79:205-221
58. Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, Humala N, Seror I, Bartholomew S, Rosendorff C, Pasinetti GM (2007) Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 117:3393-3402
59. Zhao W, Wang J, Ho L, Ono K, Teplow DB, Pasinetti GM (2009) Identification of antihypertensive drugs which inhibit amyloid-beta protein oligomerization. J Alzheimers Dis 16:49-57